|
Volumn 85, Issue 6, 2000, Pages 670-671
|
Incidence of factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation
a a a a a a |
Author keywords
Factor V Leiden; Prothrombin G20210A; Stem cell transplantation; Thrombosis; VOD
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLOOD CLOTTING FACTOR 5 LEIDEN;
BUSULFAN;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
IDARUBICIN;
ISOENZYME;
MELPHALAN;
NORETHISTERONE;
ORAL CONTRACEPTIVE AGENT;
PROTHROMBIN;
THIOTEPA;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD CLOTTING FACTOR 5 DEFICIENCY;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DRUG MEGADOSE;
DYSPROTHROMBINEMIA;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
INCIDENCE;
LEUKEMIA;
LUNG EMBOLISM;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE MYELOMA;
THROMBOPHILIA;
VEIN OCCLUSION;
ADOLESCENT;
ADULT;
AMINO ACID SUBSTITUTION;
FACTOR V;
FEMALE;
FOLLOW-UP STUDIES;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HETEROZYGOTE;
HUMANS;
INCIDENCE;
ITALY;
MALE;
MIDDLE AGED;
POINT MUTATION;
PROTHROMBIN;
PULMONARY EMBOLISM;
THROMBOPHILIA;
VENOUS THROMBOSIS;
|
EID: 0033939695
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (9)
|